Cash & Equivalents
CME Group Cash & Equivalents decreased by 45.9% to $2.39B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 70.2%, from $1.41B to $2.39B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows an upward trend with a 22.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Detailed definition
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Peer comparison
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.08B | $1.46B | $2.83B | $2.05B | $1.88B | $2.13B | $2.72B | $1.57B | $1.88B | $2.30B | $2.91B | $1.44B | $1.79B | $2.32B | $2.89B | $1.41B | $1.98B | $2.45B | $4.42B | $2.39B |
| QoQ Change | — | +35.0% | +94.3% | -27.8% | -8.1% | +13.3% | +27.7% | -42.5% | +20.1% | +22.3% | +26.6% | -50.7% | +24.6% | +29.7% | +24.6% | -51.4% | +41.0% | +23.5% | +80.5% | -45.9% |
| YoY Change | — | — | — | — | +73.9% | +46.0% | -4.0% | -23.5% | +0.0% | +8.0% | +7.1% | -8.2% | -4.8% | +1.0% | -0.7% | -2.2% | +10.7% | +5.4% | +52.7% | +70.2% |
Cash & Equivalents at Other Companies
Frequently Asked Questions
- What is CME Group's cash & equivalents?
- CME Group (CME) reported cash & equivalents of $2.39B in Q1 2026.
- How has CME Group's cash & equivalents changed year-over-year?
- CME Group's cash & equivalents increased by 70.2% year-over-year, from $1.41B to $2.39B.
- What is the long-term trend for CME Group's cash & equivalents?
- Over 5 years (2020 to 2025), CME Group's cash & equivalents has grown at a 22.0% compound annual growth rate (CAGR), from $1.63B to $4.42B.
- What does cash & equivalents mean?
- Money in the bank and very short-term investments that can be turned into cash almost instantly.